DK3522904T3 - Flydende sammensætning til anvendelse i behandlingen af gastroesophageal reflux - Google Patents
Flydende sammensætning til anvendelse i behandlingen af gastroesophageal reflux Download PDFInfo
- Publication number
- DK3522904T3 DK3522904T3 DK17797183.5T DK17797183T DK3522904T3 DK 3522904 T3 DK3522904 T3 DK 3522904T3 DK 17797183 T DK17797183 T DK 17797183T DK 3522904 T3 DK3522904 T3 DK 3522904T3
- Authority
- DK
- Denmark
- Prior art keywords
- treatment
- liquid composition
- gastroesophageal reflux
- gastroesophageal
- reflux
- Prior art date
Links
Classifications
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
- A61K31/728—Hyaluronic acid
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/726—Glycosaminoglycans, i.e. mucopolysaccharides
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/70—Carbohydrates; Sugars; Derivatives thereof
- A61K31/715—Polysaccharides, i.e. having more than five saccharide radicals attached to each other by glycosidic linkages; Derivatives thereof, e.g. ethers, esters
- A61K31/737—Sulfated polysaccharides, e.g. chondroitin sulfate, dermatan sulfate
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
- A61K35/56—Materials from animals other than mammals
- A61K35/63—Arthropods
- A61K35/64—Insects, e.g. bees, wasps or fleas
- A61K35/644—Beeswax; Propolis; Royal jelly; Honey
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K36/00—Medicinal preparations of undetermined constitution containing material from algae, lichens, fungi or plants, or derivatives thereof, e.g. traditional herbal medicines
- A61K36/18—Magnoliophyta (angiosperms)
- A61K36/88—Liliopsida (monocotyledons)
- A61K36/886—Aloeaceae (Aloe family), e.g. aloe vera
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P1/00—Drugs for disorders of the alimentary tract or the digestive system
- A61P1/04—Drugs for disorders of the alimentary tract or the digestive system for ulcers, gastritis or reflux esophagitis, e.g. antacids, inhibitors of acid secretion, mucosal protectants
Landscapes
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Pharmacology & Pharmacy (AREA)
- Medicinal Chemistry (AREA)
- Chemical & Material Sciences (AREA)
- Epidemiology (AREA)
- Natural Medicines & Medicinal Plants (AREA)
- Molecular Biology (AREA)
- Dermatology (AREA)
- Insects & Arthropods (AREA)
- Engineering & Computer Science (AREA)
- Zoology (AREA)
- Biotechnology (AREA)
- Medical Informatics (AREA)
- Microbiology (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Animal Husbandry (AREA)
- Botany (AREA)
- Alternative & Traditional Medicine (AREA)
- Mycology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- General Chemical & Material Sciences (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Organic Chemistry (AREA)
- Medicines Containing Plant Substances (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Medicinal Preparation (AREA)
Applications Claiming Priority (2)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| IT102016000101413A IT201600101413A1 (it) | 2016-10-10 | 2016-10-10 | Composizione liquida per uso nel trattamento del reflusso gastroesofageo |
| PCT/IB2017/056254 WO2018069832A1 (en) | 2016-10-10 | 2017-10-10 | Liquid composition for use in the treatment of gastroesophageal reflux |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| DK3522904T3 true DK3522904T3 (da) | 2021-12-06 |
Family
ID=57960706
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| DK17797183.5T DK3522904T3 (da) | 2016-10-10 | 2017-10-10 | Flydende sammensætning til anvendelse i behandlingen af gastroesophageal reflux |
Country Status (9)
| Country | Link |
|---|---|
| US (2) | US11337992B2 (da) |
| EP (1) | EP3522904B1 (da) |
| DK (1) | DK3522904T3 (da) |
| ES (1) | ES2900565T3 (da) |
| HU (1) | HUE057257T2 (da) |
| IT (1) | IT201600101413A1 (da) |
| PL (1) | PL3522904T3 (da) |
| PT (1) | PT3522904T (da) |
| WO (1) | WO2018069832A1 (da) |
Families Citing this family (7)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| IT201600101413A1 (it) | 2016-10-10 | 2018-04-10 | Sofar Swiss S A | Composizione liquida per uso nel trattamento del reflusso gastroesofageo |
| IT201800004332A1 (it) * | 2018-04-09 | 2019-10-09 | Composizione liquida per uso nel trattamento della mucosa del tratto oro-faringo-laringo-esofageo | |
| IT201900008409A1 (it) * | 2019-06-07 | 2020-12-07 | Vivatis Pharma Gmbh | Individuazione e selezione di un materiale di partenza vegetale di condroitina solfato e acido ialuronico vegetali, e trasformazione di tale materiale di partenza vegetale per l’ottenimento di ingredienti per utilizzo in alimenti, integratori, dispositivi medici o farmaci |
| IT202000022477A1 (it) * | 2020-09-23 | 2022-03-23 | Sofar Swiss Sa | Composizioni comprendenti una condroitina vegetale o un suo analogo e loro uso nel trattamento disturbi della mucosa del tratto orale, faringo-laringeo e/o gastro-esofageo |
| IT202000022471A1 (it) * | 2020-09-23 | 2022-03-23 | Sofar Swiss Sa | Composizioni comprendenti una condroitina vegetale o un suo analogo e loro uso nel trattamento disturbi della mucosa del tratto orale, faringo-laringeo e/o gastro-esofageo |
| IT202100021995A1 (it) * | 2021-08-27 | 2023-02-27 | Neilos S R L | Composizione per la prevenzione e/o il trattamento delle patologie gastriche ed esofagee |
| IT202100021992A1 (it) * | 2021-08-27 | 2023-02-27 | Neilos S R L | Composizione per la prevenzione e/o il trattamento delle patologie gastriche ed esofagee |
Family Cites Families (18)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| JPS6147418A (ja) | 1984-08-13 | 1986-03-07 | Seikagaku Kogyo Co Ltd | ヒアルロン酸含有胃粘膜保護剤 |
| US5178878A (en) | 1989-10-02 | 1993-01-12 | Cima Labs, Inc. | Effervescent dosage form with microparticles |
| WO2004044009A1 (en) | 2002-11-13 | 2004-05-27 | Cargill, Incorporated | Isolating chondroitin sulfate |
| US8815916B2 (en) | 2004-05-25 | 2014-08-26 | Santarus, Inc. | Pharmaceutical formulations useful for inhibiting acid secretion and methods for making and using them |
| ES2335529T3 (es) * | 2005-07-21 | 2010-03-29 | Kabushiki Kaisha Yakult Honsha | Bacteria nueva que pertenece al genero bifidobacterium y utilizacion de la misma. |
| US20090208588A1 (en) * | 2008-02-19 | 2009-08-20 | Roger Wayne Brown | GERD carbohydrate compositions |
| PT2296670E (pt) * | 2008-05-13 | 2013-03-25 | Apharm Srl | Utilização oral de glicosaminoglicana e composições |
| DE102008034944B4 (de) * | 2008-07-26 | 2017-03-16 | Arivine Pharma Ag | Mikroemulsion |
| US8362025B2 (en) * | 2008-12-22 | 2013-01-29 | Hydra Biosciences, Inc. | Compositions useful for treating disorders related to TRPA1 |
| PT2435021E (pt) | 2009-05-25 | 2013-09-30 | Sofar Swiss Sa | Utilização de uma combinação fixa de glicosaminoglicano e composição mastigável compreendendo a referida combinação fixa |
| WO2010144865A2 (en) | 2009-06-12 | 2010-12-16 | Meritage Pharma, Inc. | Methods for treating gastrointestinal disorders |
| US20110038945A1 (en) * | 2009-08-13 | 2011-02-17 | Gear Gavin M | Orally ingestable medicament and method for treating a heartburn inducing event or an acid reflux episode in a living human subject |
| WO2014078623A2 (en) | 2012-11-15 | 2014-05-22 | Brandeis University | Tethering cysteine residues using cyclic disulfides |
| EP2886107A1 (en) | 2013-12-17 | 2015-06-24 | ObsEva S.A. | Oral formulations of pyrrolydine derivatives |
| EA037070B9 (ru) | 2015-10-01 | 2021-03-29 | Афарм С.Р.Л. | Комбинация гликозаминогликанов и антацидного агента и содержащая ее композиция |
| IT201600101413A1 (it) | 2016-10-10 | 2018-04-10 | Sofar Swiss S A | Composizione liquida per uso nel trattamento del reflusso gastroesofageo |
| IT201700124424A1 (it) | 2017-10-31 | 2019-05-01 | Sofar Swiss Sa | Compressa da succhiare e/o sciogliere in bocca a base di acido ialuronico e condroitina solfato e loro sali |
| IT201700124434A1 (it) | 2017-10-31 | 2019-05-01 | Sofar Swiss Sa | Compressa da succhiare e/o sciogliere in bocca a base di acido ialuronico e condroitina solfato e loro sali per uso nel trattamento di una sottopopolazione di pazienti GERD. |
-
2016
- 2016-10-10 IT IT102016000101413A patent/IT201600101413A1/it unknown
-
2017
- 2017-10-10 WO PCT/IB2017/056254 patent/WO2018069832A1/en unknown
- 2017-10-10 ES ES17797183T patent/ES2900565T3/es active Active
- 2017-10-10 DK DK17797183.5T patent/DK3522904T3/da active
- 2017-10-10 HU HUE17797183A patent/HUE057257T2/hu unknown
- 2017-10-10 PL PL17797183T patent/PL3522904T3/pl unknown
- 2017-10-10 EP EP17797183.5A patent/EP3522904B1/en active Active
- 2017-10-10 PT PT177971835T patent/PT3522904T/pt unknown
- 2017-10-10 US US16/340,813 patent/US11337992B2/en active Active
-
2022
- 2022-05-12 US US17/743,362 patent/US11690867B2/en active Active
Also Published As
| Publication number | Publication date |
|---|---|
| US20220265701A1 (en) | 2022-08-25 |
| PT3522904T (pt) | 2021-12-13 |
| US11337992B2 (en) | 2022-05-24 |
| ES2900565T3 (es) | 2022-03-17 |
| EP3522904B1 (en) | 2021-09-15 |
| US11690867B2 (en) | 2023-07-04 |
| IT201600101413A1 (it) | 2018-04-10 |
| WO2018069832A1 (en) | 2018-04-19 |
| EP3522904A1 (en) | 2019-08-14 |
| US20190262388A1 (en) | 2019-08-29 |
| PL3522904T3 (pl) | 2022-02-07 |
| HUE057257T2 (hu) | 2022-05-28 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| DK3119397T3 (da) | Heterocykliske forbindelser til anvendelse i behandling af PI3K-gamma-medierede lidelser | |
| DK3307262T3 (da) | Forbindelser til anvendelse ved behandling af neuromuskulære lidelser | |
| DK3481846T3 (da) | 11-substituerede 24-hydroxysteroler til anvendelse til behandling af nmda-relaterede tilstande | |
| DK3522904T3 (da) | Flydende sammensætning til anvendelse i behandlingen af gastroesophageal reflux | |
| DK3185957T3 (da) | Patisiran til anvendelse ved behandlingen af transthyretin-medieret amyloidosis | |
| DK3102673T3 (da) | Fremgangsmåder og sammensætninger til behandling af beta-talassæmi | |
| DK3882250T3 (da) | Tetrahydropyranyl-amino-pyrrolopyrimidinon til anvendelse i behandling af btk-medierede forstyrrelser | |
| DK3197472T3 (da) | Rekombinante phe-frie proteiner til anvendelse i behandlingen af phenylketonuri | |
| DK3811943T3 (da) | Forbindelse til anvendelse til behandling af øjenlidelser | |
| DK3307296T3 (da) | Timp2 til anvendelse til behandling af aldringsassocierede tilstande | |
| DK3177659T3 (da) | Nitrogenholdige forbindelser egnede til anvendelse ved fremstilling af polyurethaner | |
| DK3524255T3 (da) | Sammensætning til behandling af acne | |
| DK3556383T3 (da) | Plasminogen til anvendelse ved behandling af diabetes | |
| DK3391902T3 (da) | Plasminogen til anvendelse i behandlingen af diabetisk angiokardiopati | |
| DK3204038T3 (da) | Sammensætninger omfattende amylase til anvendelse i behandlingen af pruritus | |
| DK3456330T3 (da) | Cortexolon-17alpha-valerat til anvendelse ved behandling af tumorer | |
| DK3050561T3 (da) | Sammensætninger af chlorogensyre og fremgangsmåder til fremstilling og anvendelse af samme i fedmehåndtering | |
| DK3160234T3 (da) | Sammensætning til anvendelse til forebyggelse og behandling af oftalmisk-, hånd- eller fodbiofilmvækst | |
| DK3302519T3 (da) | Ornithodoros-moubata-komplement-inhibitor til anvendelse i behandlingen af akut graft-versus-host-sygdom | |
| DK3328864T3 (da) | Terapeutiske forbindelser og sammensætninger til behandling af sociale forstyrrelser og stofmisbrugsforstyrrelser | |
| DK3374497T3 (da) | Modificerede makrofager til anvendelse i behandlingen af kræft | |
| DK3423060T3 (da) | Imatinib til anvendelse til behandling af slagtilfælde | |
| DK3149049T3 (da) | Il-22 til anvendelse til behandling af stofskiftesygdomme | |
| DK3551189T3 (da) | Alprazolam til anvendelse ved behandling af epilepsi | |
| DK3522873T3 (da) | Sammensætninger og fremgangsmåder til behandlingen af xerostomi |